Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patients

Methylation of the O(6)-Methylguanine-DNA methyltransferase (MGMT) promoter is predictive for treatment response in glioblastoma patients. However, precise predictive cutoff values to distinguish “MGMT methylated” from “MGMT unmethylated” patients remain highly debated in terms of pyrosequencing (PS...

Descripción completa

Detalles Bibliográficos
Autores principales: Radke, Josefine, Koch, Arend, Pritsch, Fabienne, Schumann, Elisa, Misch, Martin, Hempt, Claudia, Lenz, Klaus, Löbel, Franziska, Paschereit, Fabienne, Heppner, Frank L., Vajkoczy, Peter, Koll, Randi, Onken, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549362/
https://www.ncbi.nlm.nih.gov/pubmed/31167648
http://dx.doi.org/10.1186/s40478-019-0745-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549362/
https://www.ncbi.nlm.nih.gov/pubmed/31167648
http://dx.doi.org/10.1186/s40478-019-0745-z

Ejemplares similares